Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma

Table 3 Results of TP regimen plus radiotherapy for loco-regionally advanced esophageal cancer in past studies

Ref.	No.	Chemotherapy	Dose and fraction	Grade ≥ 3 acute hematologic toxicity	Median observation period (mo)	Median survival t/mo	2-yr survival rate
Jingu et al[22]	84	PTX 135 mg/m2	50.4 Gy/28 fractions	40.00%	NA	14.9	37.00%
		DDP 75 mg/m2
		3-wk based
Tu et al[21]	36	PTX 135 mg/m2	52-70 Gy/1.8-2 fractions	13.90%	14	18	42.80%
		DDP 75 mg/m2
		3-wk based
Song et al[20]	82	PTX 135 mg/m2	60 Gy/30 fractions	30.50%	20.4	18.2	40.80%
		DDP 30 mg/m2
		4-wk based

DDP: Cisplatin; PTX: Paclitaxel; RT: Radiotherapy; NA: Not available.